Back to the North Carolina Tar Heels Newsfeed

FDA grants emergency authorization to use antiviral drug remdesivir developed at UNC

After a trial showed the drug remdesivir produced by the company Gilead effectively treats coronavirus, the U.S. Food and Drug Administration issued an emergency-use authorization for hospitalized COVID-19 patients, CNN reported. A study out of the University of North Carolina showed that the drug reduces recovery time in coronavirus patients. (Miami Herald)

Recent Campus Connections News:

Meet the UNC scientist working on a cure for coronavirus
Timothy Sheahan isn’t just a professor. He’s also a research scientist at the Gillings School of Global Public Health at UNC. The lab he works.